Annual Cash & Cash Equivalents
$4.96 M
-$3.54 M-41.61%
01 September 2023
Summary:
Bright Minds Biosciences annual cash & cash equivalents is currently $4.96 million, with the most recent change of -$3.54 million (-41.61%) on 01 September 2023. During the last 3 years, it has fallen by -$10.53 million (-67.96%). DRUG annual cash & cash equivalents is now -67.96% below its all-time high of $15.49 million, reached on 30 September 2021.DRUG Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$4.52 M
+$128.90 K+2.94%
01 June 2024
Summary:
Bright Minds Biosciences quarterly cash and cash equivalents is currently $4.52 million, with the most recent change of +$128.90 thousand (+2.94%) on 01 June 2024. Over the past year, it has dropped by -$444.90 thousand (-8.96%). DRUG quarterly cash and cash equivalents is now -77.58% below its all-time high of $20.16 million, reached on 31 March 2021.DRUG Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DRUG Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -9.0% |
| 3 y3 years | -68.0% | -70.8% |
| 5 y5 years | - | - |
DRUG Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -68.0% | at low | -70.8% | +2.9% |
| 5 y | 5 years | -68.0% | +730.7% | -77.6% | +656.3% |
| alltime | all time | -68.0% | +730.7% | -77.6% | +656.3% |
Bright Minds Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $4.52 M(+2.9%) |
| Mar 2024 | - | $4.39 M(-13.9%) |
| Dec 2023 | - | $5.10 M(+2.7%) |
| Sept 2023 | $4.96 M(-41.6%) | $4.96 M(-19.1%) |
| June 2023 | - | $6.14 M(-14.2%) |
| Mar 2023 | - | $7.15 M(-13.4%) |
| Dec 2022 | - | $8.26 M(-2.8%) |
| Sept 2022 | $8.50 M | $8.50 M(+26.8%) |
| June 2022 | - | $6.71 M(-27.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $9.19 M(-22.5%) |
| Dec 2021 | - | $11.86 M(-23.5%) |
| Sept 2021 | $15.49 M(+2492.3%) | - |
| Sept 2021 | - | $15.49 M(-12.7%) |
| June 2021 | - | $17.75 M(-12.0%) |
| Mar 2021 | - | $20.16 M(+1145.1%) |
| Dec 2020 | - | $1.62 M(+171.0%) |
| Sept 2020 | $597.60 K | - |
| Sept 2020 | - | $597.60 K |
FAQ
- What is Bright Minds Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly cash and cash equivalents year-on-year change?
What is Bright Minds Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of DRUG is $4.96 M
What is the all time high annual cash & cash equivalents for Bright Minds Biosciences?
Bright Minds Biosciences all-time high annual cash & cash equivalents is $15.49 M
What is Bright Minds Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of DRUG is $4.52 M
What is the all time high quarterly cash and cash equivalents for Bright Minds Biosciences?
Bright Minds Biosciences all-time high quarterly cash and cash equivalents is $20.16 M
What is Bright Minds Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, DRUG quarterly cash and cash equivalents has changed by -$444.90 K (-8.96%)